- The trend backdrop is active with a 41-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
MRK
MEX
Week ended 07 Aug 2026
Weekly Investor Report
Merck & Co., Inc. · Healthcare · Drug Manufacturers - General
Latest close
2,200 MXN
-2.8%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 5.7% above the Trend Line and sits at 86.1% of its 52-week range. The latest completed week returned -2.8%, after a 1.9% four-week move. The latest news-sentiment score is 68/100. Near-term considerations: volume confirmation is below normal.
Setup score
63
out of 100
Latest Close
2,200 MXN
7 Aug 2026
1W Return
-2.8%
latest completed week
4W Return
1.9%
short-term follow-through
12W Return
13.7%
quarterly tape
Trend Breadth
78.8%
41 of 52 weeks active
Volume Ratio
0.4x
vs 13-week average
- Next-week expectancy is negative at 43.61% based on similar historical setup states.
- 2 reversal markers appear in the recent smart-money tape.
- Latest weekly return ranks in the weaker part of its sector group.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.8%
Latest completed week; four-week move 1.9%.
Indicator stack
88/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 43.61%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
68/100
11 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 5.7% above the Trend Line and sits at 86.1% of its 52-week range. The latest completed week returned -2.8%, after a 1.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7012-week average 0.64
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.70Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 1.9% over four weeks, 13.7% over 12 weeks, and 46.7% over one year. The current trend has remained active for 41 consecutive weeks.
Performance by holding period
Active trend streak41 weeks
Active weeks in one year41
Trend breadth78.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.85Latest activity-pressure read.
Pressure change1365.7%Four-week change in activity pressure.
Leadership12.93Latest relative-leadership reading.
RS change-6.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment68/100
Weighted news tone is positive across 11 relevant articles.
9 positive · 1 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-5.3%Distance below the 52-week high.
13-week volatility5.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2616 weeks finished lower.
Best week+14.9%Week of 26 Jun.
Worst week-7.3%Week of 19 Jun.
Latest week-2.8%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains6
Flat weeks0
Modest losses13
Sharp losses3
Recent vol5.6%13-week weekly-return volatility.
Base vol4.5%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew4.9% / -2.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorMX Healthcare
4-week rank24 / 78
Group average-1.2%
Trend breadth29.5%
Trend29.5%active weekly trend signals
MD62.8%positive activity pressure
RS35.9%positive relative leadership
Four-week leaders
IndustryMX Drug Manufacturers - General
4-week rank5 / 14
Group average1.1%
Trend breadth42.9%
Trend42.9%active weekly trend signals
MD78.6%positive activity pressure
RS64.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape66/100
Trend, activity pressure, participation, and risk combine to a 66/100 tape read.
Indicator analysis70/100Latest 12-week confirmation: trend 12/12, activity pressure 5/12, relative leadership 12/12.
Activity pressure 0.70; 2 reversal markers Next-Week ExpectancyNegative 43.61%Next-week expectancy is negative with a 43.61% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment68/100Weighted news tone is positive across 11 relevant articles.
5 Insightful Analyst Questions From Merck’s Q2 Earnings Call Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 2,200 MXN | -2.8% | 2,082 MXN | 1,935 MXN | 0.85 | 12.93 | 3.5K | On |
| 31 Jul 2026 | 2,263 MXN | -1.6% | 2,076 MXN | 1,932 MXN | 0.92 | 16.71 | 2.9K | On |
| 24 Jul 2026 | 2,300 MXN | 0.9% | 2,063 MXN | 1,929 MXN | 0.79 | 20.20 | 28.7K | On |
| 17 Jul 2026 | 2,278 MXN | 5.5% | 2,050 MXN | 1,926 MXN | 0.59 | 19.20 | 12.1K | On |
| 10 Jul 2026 | 2,159 MXN | -3.6% | 2,035 MXN | 1,923 MXN | 0.06 | 13.76 | 39.4K | On |
| 3 Jul 2026 | 2,240 MXN | -0.0% | 2,023 MXN | 1,920 MXN | -0.19 | 17.43 | 0 | On |
| 26 Jun 2026 | 2,241 MXN | 14.9% | 2,009 MXN | 1,918 MXN | -0.34 | 17.78 | 5.9K | On |
| 19 Jun 2026 | 1,950 MXN | -7.3% | 1,998 MXN | 1,916 MXN | -0.63 | 2.30 | 0 | On |
| 12 Jun 2026 | 2,103 MXN | -0.2% | 1,993 MXN | 1,916 MXN | -0.45 | 10.04 | 0 | On |
| 5 Jun 2026 | 2,106 MXN | 2.1% | 1,979 MXN | 1,915 MXN | -0.63 | 13.57 | 6.4K | On |
| 29 May 2026 | 2,062 MXN | -2.5% | 1,962 MXN | 1,914 MXN | -0.81 | 7.67 | 4.3K | On |
| 22 May 2026 | 2,115 MXN | 9.3% | 1,947 MXN | 1,913 MXN | -0.92 | 11.15 | 5.9K | On |
| 15 May 2026 | 1,934 MXN | 1.0% | 1,930 MXN | 1,912 MXN | -1.08 | 2.56 | 14.3K | On |
| 8 May 2026 | 1,916 MXN | -0.4% | 1,917 MXN | 1,912 MXN | -1.00 | -0.95 | 7.3K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.